These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15530830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA, Stadelmann C, Diem R, Bähr M, Brück W, Gold R.
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):715-27. PubMed ID: 16355314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Future neuroprotective strategies.
    Sättler MB, Bähr M.
    Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
    [Abstract] [Full Text] [Related]

  • 7. Emerging therapies in multiple sclerosis.
    Farrell R, Heaney D, Giovannoni G.
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):797-816. PubMed ID: 16262563
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis.
    Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C.
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA.
    Neurology; 2007 May 29; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S, Sorensen PS.
    J Neurol Sci; 2005 Jun 15; 233(1-2):61-5. PubMed ID: 15949496
    [Abstract] [Full Text] [Related]

  • 13. [Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis].
    Moreno B, Espejo C, Mestre L, Suardiaz M, Clemente D, de Castro F, Fernández-Fernández Ó, Montalban X, Villoslada P, Guaza C, Spanish Network for MS.
    Rev Neurol; 2012 Jan 16; 54(2):114-24. PubMed ID: 22234570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
    Steinman L, Lindsey JW, Alters S, Hodgkinson S.
    Immunol Ser; 1993 Jan 16; 59():253-60. PubMed ID: 8461390
    [No Abstract] [Full Text] [Related]

  • 16. Evaluating the validity of animal models for research into therapies for immune-based disorders.
    't Hart BA, Amor S, Jonker M.
    Drug Discov Today; 2004 Jun 15; 9(12):517-24. PubMed ID: 15183159
    [Abstract] [Full Text] [Related]

  • 17. Future research directions in multiple sclerosis therapies.
    Greenberg BM, Calabresi PA.
    Semin Neurol; 2008 Feb 15; 28(1):121-7. PubMed ID: 18256992
    [Abstract] [Full Text] [Related]

  • 18. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B, Hartung HP.
    Ann Neurol; 2007 Oct 15; 62(4):314-26. PubMed ID: 17969020
    [Abstract] [Full Text] [Related]

  • 19. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T, Ziemssen F.
    Autoimmun Rev; 2005 Sep 15; 4(7):460-7. PubMed ID: 16137612
    [Abstract] [Full Text] [Related]

  • 20. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).
    't Hart BA, Massacesi L.
    J Neuropathol Exp Neurol; 2009 Apr 15; 68(4):341-55. PubMed ID: 19337065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.